You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
BioMistral did not achieve competitive performance under the current experimental setup. This illustration summarizes the investigation, highlighting potential factors such as CUDA/code efficiency, dataset compatibility, hyperparameter optimization, and implementation-specific challenges that require further exploration.
🩺 AstraMed: A Clinical Risk Intelligence Platform. Powered by SOTA Ensemble ML & BioMistral-7B for predictive medical analytics and explainable risk scoring.
Clinical-grade brain tumor diagnostics powered by interpretable deep learning (ResNet-50 + Grad-CAM). Features 3D spatial mapping, BioMistral narratives, and high-fidelity reporting. Engineered for medical transparency. #NeuroOncology #DiagnosticAI